PGFG
BSX icon

Pine Grove Financial Group’s Boston Scientific BSX Stock Holding History

Pine Grove Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
9,986
+6,136
+159% +$333K 0.04% 146
2026
Q1 		$242K Buy
3,850
+1,025
+36% +$82K 0.03% 168
2025
Q4 		$269K Buy
+2,825
New +$277K 0.03% 162

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pine Grove Financial Group's BSX Position: Q2 2026 in Review

Pine Grove Financial Group increased its Boston Scientific (BSX) stake by 159% in Q2 2026, buying an estimated $333K and bringing the position to 9,986 shares worth $426K. The position accounts for 0.04% of the portfolio, ranked #146.

Pine Grove Financial Group first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pine Grove Financial Group held 9,986 shares of Boston Scientific worth $426K as of Q2 2026.
  • Pine Grove Financial Group bought 6,136 Boston Scientific shares in Q2 2026, an estimated $333K.
  • Boston Scientific made up 0.04% of Pine Grove Financial Group's portfolio in Q2 2026, its #146 holding.
  • Pine Grove Financial Group first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pine Grove Financial Group's 13F filing for Q2 2026, filed 2 Sep 2026.